BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35115366)

  • 21. Human Radiation Dosimetry for Orally and Intravenously Administered
    Srinivasan S; Crandall JP; Gajwani P; Sgouros G; Mena E; Lodge MA; Wahl RL
    J Nucl Med; 2020 Apr; 61(4):613-619. PubMed ID: 31628217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of
    Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A
    Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimation of kidneys and urinary bladder doses based on the region of interest in
    Mustapha FA; Bashah FAA; Yassin IM; Fathinul Fikri AS; Nordin AJ; Abdul Razak HR
    Quant Imaging Med Surg; 2017 Jun; 7(3):310-317. PubMed ID: 28811997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDG PET/CT of a late-term pregnant woman with breast cancer.
    Hsieh TC; Wu YC; Sun SS; Chu LY; Yen KY; Kao CH
    Clin Nucl Med; 2012 May; 37(5):489-91. PubMed ID: 22475901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proposed addendum to previously published fetal dose estimate tables for 18F-FDG.
    Stabin MG
    J Nucl Med; 2004 Apr; 45(4):634-5. PubMed ID: 15073260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining optimal tracer activities in pediatric oncologic whole-body
    Gatidis S; Schmidt H; la Fougère C; Nikolaou K; Schwenzer NF; Schäfer JF
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2283-2289. PubMed ID: 27565153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.
    Bretin F; Bahri MA; Bernard C; Warnock G; Aerts J; Mestdagh N; Buchanan T; Otoul C; Koestler F; Mievis F; Giacomelli F; Degueldre C; Hustinx R; Luxen A; Seret A; Plenevaux A; Salmon E
    Mol Imaging Biol; 2015 Aug; 17(4):557-64. PubMed ID: 25595813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Embryo/Fetus Doses from
    Işıkçı Nİ; Demir M
    J Med Phys; 2022; 47(1):109-113. PubMed ID: 35548038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation dose of 18F-FDG to lactating breasts, its effect on the effective dose and a more accurate effective dose from 18F-FDG.
    Pencharz D; McMeekin H; Wagner T; Wickham F
    Nucl Med Commun; 2016 Aug; 37(8):860-4. PubMed ID: 27115065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of the beta+ dose to the embryo resulting from 18F-FDG administration during early pregnancy.
    Zanotti-Fregonara P; Champion C; Trébossen R; Maroy R; Devaux JY; Hindié E
    J Nucl Med; 2008 Apr; 49(4):679-82. PubMed ID: 18344434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.
    Sawicki LM; Grueneisen J; Schaarschmidt BM; Buchbender C; Nagarajah J; Umutlu L; Antoch G; Kinner S
    Eur J Radiol; 2016 Feb; 85(2):459-65. PubMed ID: 26781152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient-Specific Computational Model and Dosimetry Calculations for PET/CT of a Patient Pregnant with Twins.
    Xie T; Zanotti-Fregonara P; Edet-Sanson A; Zaidi H
    J Nucl Med; 2018 Sep; 59(9):1451-1458. PubMed ID: 29371408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of
    Sah BR; Ghafoor S; Burger IA; Ter Voert EEGW; Sekine T; Delso G; Huellner M; Dedes KJ; Boss A; Veit-Haibach P
    J Nucl Med; 2018 Dec; 59(12):1817-1822. PubMed ID: 29880506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma.
    Ponisio MR; McConathy J; Laforest R; Khanna G
    Pediatr Radiol; 2016 Aug; 46(9):1258-68. PubMed ID: 27003132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Noninvasive estimation of human radiation dosimetry of
    Shidahara M; Funaki Y; Watabe H
    Appl Radiat Isot; 2022 Mar; 181():110071. PubMed ID: 34952332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. National and local diagnostic reference levels for adult
    Alhorani Q; Alkhybari E; Rawashdeh M; Sabarudin A; Latiff RA; Al-Ibraheem A; Mohamad M
    J Radiol Prot; 2024 Mar; 44(1):. PubMed ID: 38387102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ferumoxytol Does Not Impact Standardized Uptake Values on PET/MR Scans.
    Muehe AM; Yerneni K; Theruvath AJ; Thakor AS; Pribnow A; Avedian R; Steffner R; Rosenberg J; Hawk KE; Daldrup-Link HE
    Mol Imaging Biol; 2020 Jun; 22(3):722-729. PubMed ID: 31325083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
    Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA
    Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in
    Plyku D; Hobbs RF; Huang K; Atkins F; Garcia C; Sgouros G; Van Nostrand D
    J Nucl Med; 2017 Jul; 58(7):1146-1154. PubMed ID: 28104741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.